Salvage Breast-Conserving Surgery and Reirradiation With Intraoperative Electrons for Recurrent Breast Cancer: A Multicentric Study on Behalf of Italian Association of Radiotherapy and Clinical Oncology (AIRO)
Practical Radiation Oncology · 2024
DOI: 10.1016/j.prro.2024.05.012 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Practical Radiation Oncology, 2024. Verfasst von Maria Cristina Leonardi und 29 weiteren Autor:innen. Beteiligte Einrichtung: Radiotherapy Division, European Institute of Oncology, IEO IRCCS, Milan, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Segmental, Neoplasm Recurrence, Local, Salvage Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Fondazione Istituto Europeo di Oncologia e Centro Cardiologico Monzino, American-Italian Cancer Foundation, Fondazione Umberto Veronesi.
Abstract (Originalsprache)
PURPOSE: Intraoperative radiation therapy with electrons (IOERT) may represent a viable choice for partial breast reirradiation after repeat quadrantectomy for local recurrence (LR) for primary breast cancer (BC) in lieu of mastectomy. METHODS AND MATERIALS: A database collecting data on partial breast reirradiation with IOERT from 8 Italian centers was set up in 2016 to 2018, providing data on cumulative incidence (CumI) of second LR and survival with a long follow-up. RESULTS: From 2002 to 2015, 109 patients underwent the conservative retreatment. The median primary BC first LR interval was 11.1 years (range, 2.4-27.7). The median first LR size was 0.9 cm (range, 0.3-3.0), and 43.6% cases were luminal A. Median IOERT dose was 18 Gy (range, 12-21), and median collimator diameter was 4 cm (range, 3-6). Median follow-up duration was 11.7 years (IQR, 7.7-14.6). The second LR CumI was 12.2% (95% CI, 6.8%-19.2%) at 5 years and 32.3% at 10 years (95% CI, 22.8%-42.2%), occurring in the same site as the first LR in about half of the cases. Human epidermal growth factor receptor 2 status and collimator size were independent LR predictors. The 5- and 10-year overall survival rates were 95.2% and 88.3%, respectively, whereas 5- and 10-year BC-specific survival rates were 98% and 94.5%, respectively. The development of a second LR significantly reduced BC-specific survival (hazard ratio, 9.40; P < .001). Grade ≥3 fibrosis rate was 18.9%. Patient-reported cosmesis was good/excellent in 59.7% of the cases. CONCLUSIONS: Second LR CumI was within the range of the literature but higher than expected, opening questions on radiation field extension and fractionation schedule. Because a second LR worsened the outcome, salvage modality must be carefully planned.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Radiotherapy Division, European Institute of Oncology, IEO IRCCS, Milan, Italy.
- Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
- Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
- Radiotherapy Division, European Institute of Oncology, IEO IRCCS, Milan, Italy. Electronic address: damarispatricia.rojas@ieo.it.
- IRCCS Ospedale Policlinico San Martino, Genova, Italy.
- Radiotherapy Unit, San Filippo Neri Hospital, ASL Roma 1, Roma, Italy; UniCamillus International Medical University in Rome, Roma, Italy.
Förderung
- Fondazione Istituto Europeo di Oncologia e Centro Cardiologico Monzino
- American-Italian Cancer Foundation
- Fondazione Umberto Veronesi
- Ministero della Salute
- Istituto Europeo di Oncologia
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Leonardi, M. C., Fodor, A. D., Frassoni, S., Rojas, D. P., Fozza, A., Blandino, G., Ciabattoni, A., Alessandro, M., Catalano, G., Ivaldi, G. B., Martini, S., De Rose, F., Fodor, C., Veronesi, P., Galimberti, V. E., Intra, M., Cornacchia, L., Braga, F., Durante, S., …, & “Brachytherapy, Interventional Radiotherapy and Intraoperative Radiotherapy” and “Reirradiation” of AIRO Study Groups (2024). Salvage Breast-Conserving Surgery and Reirradiation With Intraoperative Electrons for Recurrent Breast Cancer: A Multicentric Study on Behalf of Italian Association of Radiotherapy and Clinical Oncology (AIRO). Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2024.05.012
Vancouver
Leonardi MC, Fodor AD, Frassoni S, Rojas DP, Fozza A, Blandino G, et al. Salvage Breast-Conserving Surgery and Reirradiation With Intraoperative Electrons for Recurrent Breast Cancer: A Multicentric Study on Behalf of Italian Association of Radiotherapy and Clinical Oncology (AIRO). Practical Radiation Oncology. 2024. doi:10.1016/j.prro.2024.05.012
BibTeX
@article{Leonardi2024,
author = {Leonardi, Maria Cristina and Fodor, Alexandru David and Frassoni, Samuele and Rojas, Damaris Patricia and Fozza, Alessandra and Blandino, Gladys and Ciabattoni, Antonella and Alessandro, Marina and Catalano, Gianpiero and Ivaldi, Giovanni Battista and Martini, Stefania and De Rose, Fiorenza and Fodor, Cristiana and Veronesi, Paolo and Galimberti, Viviana Enrica and Intra, Mattia and Cornacchia, Luigi and Braga, Francesca and Durante, Stefano and Dicuonzo, Samantha and Morra, Anna and Zaffaroni, Mattia and Cattani, Federica and Belgioia, Liliana and Palumbo, Isabella and Massaccesi, Mariangela and Bagnardi, Vincenzo and Orecchia, Roberto and Jereczek-Fossa, Barbara Alicja and “Brachytherapy, Interventional Radiotherapy and Intraoperative Radiotherapy” and “Reirradiation” of AIRO Study Groups, “Brachytherapy, Interventional Radiotherapy and Intraoperative Radiotherapy” and “Reirradiation” of AIRO Study Groups},
title = {Salvage Breast-Conserving Surgery and Reirradiation With Intraoperative Electrons for Recurrent Breast Cancer: A Multicentric Study on Behalf of Italian Association of Radiotherapy and Clinical Oncology (AIRO)},
journal = {Practical Radiation Oncology},
year = {2024},
doi = {10.1016/j.prro.2024.05.012}
}
EUVIMED